12:29 Feb 05

Panacea Biotec Ltd.

Sector Pharmaceuticals & Biotechnology Industry Biotechnology
Up
372.75
-8.15 (-2.14%)
Sector Pharmaceuticals & Biotechnology Industry Biotechnology

Panacea Biotec Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Up
372.75
-8.15 (-2.14%)
12:29 Feb 05
Quality
image/svg+xml

21/100
Low Financial Strength

Valuation
image/svg+xml

12/100
Expensive Valuation

Technical

33/100
Technically Bearish

Strength

0

Weakness

0

Opportunity

0

Threats

0

-1.02 %

ROE %

-0.64 %

ROA %

0.00

EPS

132.76

BVPS

-1.49 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
661.23 459.95 559.17 559.09 603.85
Operating Expenses +
675.1 557.9 579.23 585.01 641.74
Raw Material
311.17 218.29 212.26 221.67 262.87
Increase Decrease in Cost
-48.97 34.37 17.86 -22.13 -12.08
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
182.94 126.48 149.57 173.05 185.54
Miscellaneous Expenses
289.8 193.28 203.14 227.62 205.41
Operating Profit
-13.87 -97.95 -20.06 -25.92 -37.89
Other Income
10.97 51.66 25.8 20.66 24.28
Depreciation
43.66 39.12 36.71 34.81 34.13
Interest
180.84 4.44 3.58 3.88 5.03
Profit before tax and exceptio..
-227.4 -89.86 -34.56 -43.94 -52.77
Exceptional Items
1676.21 102.66 36.03 35.99 44.5
PBT
1448.81 12.8 1.48 -7.95 -97.27
Provision for Taxation
370.9 46.55 2.98 0.77 -0.67
Net Profit
1077.9 -33.74 -1.5 -8.72 -7.6
NET Profit after MI
1077.88 -33.24 -1.17 -8.37 -7.24
EPS
175.98 -5.43 -0.19 -1.37 -1.18
Operating Profit Margin (%)
-2.1 -21.3 -3.59 -4.64 -6.27
Net Profit Margin (%)
163.01 -7.23 -0.21 -1.5 -1.2

Panacea Biotec Ltd. Shareholding

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 72.50 72.50 72.50 72.50 72.50 72.90
FII 1.40 1.10 0.80 1.20 0.40 0.40
Public 1.80 1.80 1.50 1.40 1.10 1.10
Others 24.30 24.60 25.20 24.90 26.00 25.60
Shareholder Shares Holding %
Download Our App On: